Comparative Effectiveness of SGLT2 Inhibitors Versus Cardioselective β-Blockers on One-Year Heart Failure Hospitalization in Adults With Type 2 Diabetes: A Real-World TriNetX Analysis

Author Information

• Amogh Nagol, Drexel UniversityFollow
• Ally Murphy, Drexel UniversityFollow
• David Murillo-Garcia, Tower HealthFollow

Keywords:

Type 2 diabetes; SGLT2 inhibitors; β-blockers; heart failure; real-world evidence

Recommended Citation

Nagol, Amogh; Murphy, Ally; and Murillo-Garcia, David, "Comparative Effectiveness of SGLT2 Inhibitors Versus Cardioselective β-Blockers on One-Year Heart Failure Hospitalization in Adults With Type 2 Diabetes: A Real-World TriNetX Analysis" (2026). Tower Health Research Day. 24.
https://scholarcommons.towerhealth.org/th_researchday/2025-2026/in_person_posters/24

Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt

Not Applicable